RPAM
FLXN

Rhenman & Partners Asset Management’s Flexion Therapeutics, Inc. FLXN Stock Holding History

Rhenman & Partners Asset Management’s Portfolio FLXN Stock Details FLXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-117,265
Closed -$1.46M – 96
2019
Q1 		$1.46M Sell
117,265
-389,700
-77% -$5.21M 0.17% 72
2018
Q4 		$5.74M Sell
506,965
-25,847
-5% -$405K 0.66% 55
2018
Q3 		$9.97M Buy
532,812
+181,026
+51% +$4.16M 1% 48
2018
Q2 		$9.09M Buy
351,786
+115,100
+49% +$2.99M 0.93% 49
2018
Q1 		$5.3M Sell
236,686
-25,000
-10% -$610K 0.65% 53
2017
Q4 		$6.55M Buy
+261,686
New +$6.41M 0.89% 46

Other funds holding FLXN

MVP
Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
KCM
Kingdon Capital Management New York $597M AUM 51.11% 1-Year Est. Return